Clover Health to Participate in Upcoming Leerink 2026 Global Healthcare Conference

Rhea-AI Summary

Clover Health (Nasdaq: CLOV) said CFO Peter Kuipers will present at the Leerink 2026 Global Healthcare Conference on March 10, 2026 at 9:20 a.m. ET.

A live webcast and replay of the presentation and Q&A will be available on Clover Health's investor relations website at https://investors.cloverhealth.com/.

News Market Reaction – CLOV

+2.45%

1 alert

+2.45% News Effect

On the day this news was published, CLOV gained 2.45%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Conference date: March 10, 2026 Presentation time: 9:20 a.m. Eastern Time

2 metrics

Conference date March 10, 2026 Leerink 2026 Global Healthcare Conference presentation

Presentation time 9:20 a.m. Eastern Time Scheduled CFO presentation slot

Market Reality Check

Price: $2.00 Vol: Volume 4,385,111 is below...

low vol

$2.00 Last Close

Volume Volume 4,385,111 is below the 20-day average of 6,569,827 (relative volume 0.67). low

Technical Price $2.02 is below the 200-day moving average of $2.81 and sits near the 52-week low of $2.01 (vs. 52-week high $4.80).

Peers on Argus

Sector moves were mixed: peers like MOH gained 5.43%, while PGNY and OSCR fell 2...

Sector moves were mixed: peers like MOH gained 5.43%, while PGNY and OSCR fell 2.41% and 2.54% respectively, suggesting this conference announcement was stock-specific rather than part of a broad sector move.

Historical Context

5 past events · Latest: Jan 29 (Neutral)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Jan 29	Earnings timing update	Neutral	-1.3%	Announced date and webcast details for Q4 and full-year 2025 results.
Jan 14	Membership and outlook	Positive	+10.6%	Reported 53% Medicare Advantage growth to 153,000 members and 2026 GAAP profitability goal.
Jan 12	Clinical impact update	Positive	+1.5%	Highlighted AI-enabled clinical platform outcomes and top nationwide HEDIS score for PPO plan.
Dec 16	Conference participation	Neutral	+0.8%	Announced CEO presentation at 2026 J.P. Morgan Healthcare Conference with webcast access.
Nov 17	Conference participation	Neutral	+0.0%	CFO participation in 2025 Citi Global Healthcare Conference with webcast and replay.

Pattern Detected

Operational and membership growth updates have previously coincided with positive price reactions, while conference participation and scheduling news have seen minimal impact.

Recent Company History

Over the last few months, Clover Health has highlighted growth and visibility milestones. On Jan 14, 2026, it reported a 53% year-over-year Medicare Advantage membership increase to 153,000 members and flagged an expectation of first-ever full-year GAAP net income profitability in 2026, which saw a 10.63% price gain. Prior conference participation announcements on Dec 16, 2025 and Nov 17, 2025 produced minimal moves (≤0.76%), similar in nature to today’s Leerink conference notice.

Market Pulse Summary

This announcement details Clover Health’s participation in the Leerink 2026 Global Healthcare Confer...

Analysis

This announcement details Clover Health’s participation in the Leerink 2026 Global Healthcare Conference on March 10, 2026, where the CFO will present at 9:20 a.m. ET. It fits a pattern of regular conference appearances, similar to prior J.P. Morgan and Citi events that mainly enhanced visibility rather than redefining fundamentals. Investors may watch for any updated commentary that builds on the earlier 53% Medicare Advantage membership growth and 2026 GAAP profitability expectations discussed in January materials.

AI-generated analysis. Not financial advice.

WILMINGTON, Del., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will present at the Leerink 2026 Global Healthcare Conference on Tuesday, March 10, 2026, at 9:20 a.m. Eastern Time.

A live webcast and replay of the presentation and Q&A session will be accessible on Clover Health's investor relations website at https://investors.cloverhealth.com/.

About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and aim to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on Medication Adherence, Congestive Heart Failure, Chronic Obstructive Pulmonary Disease, and in Underserved Populations as well as the earlier identification and management of Diabetes and Chronic Kidney Disease.

Investor Relations:
Ryan Schmidt
investors@cloverhealth.com

Press Inquiries:
press@cloverhealth.com

FAQ

When will Clover Health (CLOV) present at the Leerink 2026 Global Healthcare Conference?

Clover Health will present on March 10, 2026 at 9:20 a.m. Eastern Time. According to the company, CFO Peter Kuipers will lead the presentation and participate in a follow-up Q&A session available via live webcast and later replay on the investor site.

Who from Clover Health (CLOV) is presenting at the Leerink 2026 conference?

Clover Health's Chief Financial Officer, Peter Kuipers, will present at the conference. According to the company, Kuipers will deliver remarks and join a Q&A session that will be webcast live and posted for replay on the investor relations website.

How can investors watch Clover Health's (CLOV) Leerink 2026 presentation and Q&A?

Investors can watch via live webcast and access a replay on the company's investor relations website. According to the company, both the live stream and the replay will be hosted at https://investors.cloverhealth.com/ for on-demand viewing.

Will Clover Health (CLOV) make the presentation slides available after the Leerink 2026 session?

The company announced a live webcast and replay; slide availability was not specified. According to the company, the webcast and replay will be accessible on the investor relations website, where any additional materials would typically be posted.

What time zone is used for Clover Health's (CLOV) Leerink 2026 presentation on March 10, 2026?

The presentation time is given in Eastern Time: 9:20 a.m. ET on March 10, 2026. According to the company, the scheduled start is 9:20 a.m. Eastern, with the webcast and replay available online afterwards.